TrialAntimicrobial agents and chemotherapy2024

Safety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trial.

Heidi Segers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.